AKT1 and ovarian carcinoma: To further investigate whether PI3K/AKT signalling pathway is involved in the mechanism underlying the anti‐oncogene effects of AMPH1 in ovarian cancer, we evaluated the association between AMPH1 and p‐PI3K or p‐AKT.